Sunshine Heart's C-Pulse? Implantable Heart Assist Device, Made From Two PTG Polymers Passes 5-year Durability Testing The Polymer Technology Group (PTG), a preeminent biomaterials company, announced today that its customer, Sunshine Heart Inc., has passed the five-year milestone on durability-testing of its C-Pulse? implantable heart assist device.
Source: www.medicalnewstoday.comBlack Churches In Florida, Nationwide, Launch HIV/AIDS Testing Initiative Targeted Toward Black Community Black religious leaders across Florida have launched a joint initiative between the state Department of
Health and the African Methodist Episcopal Church to establish an HIV/AIDS testing site in at least one church in every county in an effort to address the high HIV/AIDS rate among black state residents, the Orlando Sentinel reports.
Source: www.medicalnewstoday.comNoninvasive Glucose Monitoring: The Elusive Goose The Technical insights Group at Frost & Sullivan is pleased to announce its 2008 Quarterly Analyst Briefing Presentation on the Noninvasive Glucose Monitoring market to be held on Tuesday, April 22, 2008 at 10:00 a.m. CDT / 11:00 a.m. EDT.
Source: www.medicalnewstoday.comPresence Of Amphiregulin Autocrine-loop Predicts Sensitivity Of EGFR Wild Type Cancers To Gefitinib And Cetuximab Researchers have discovered a biomarker in epidermal growth factor receptor (EGFR) wild-type non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC) cell lines. This so-called amphiregulin autocrine loop appears to predict response to the targeted therapies gefitinib and cetuximab.
Source: www.medicalnewstoday.com
# posted by Network @ 4:00 PM
